François Garnier

Ipsen (Paris)
Executive Vice-President, General Counsel

François Garnier was International Chief Counsel (outside the US) of Pfizer Inc. since January 2014. He joined Pfizer France, in April 2003, as Vice President, General Counsel before moving on to become Chief Counsel for Pfizer’s operations in Europe in January 2009, a position he held until January 2014. François Garnier began his career in March 1989 at Servier S.A. as International Contracts Manager and remained with the firm until September 1995. He then moved to Rhône Poulenc Rorer S.A. to take up the position of Counsel for Corporate Transactions. In May 1996, he moved to the United States as Associate Counsel, before being appointed Chief Counsel for France in May 1999. François Garnier continued his career as Chief Counsel at Aventis Animal Nutrition until September 2001, when he joined the Pharmacia Group as Chief Counsel for Europe. François Garnier has been appointed Executive Vice President, General Counsel for the Ipsen Group effective as of January 5, 2015.

Linked authors

Eiffage, Ipsen (Paris)
University Paris I Panthéon-Sorbonne
French State Council (Paris)
Institut d’économie Industrielle (IDEI)
ESSEC Business School (Cergy)
Oxera (Brussels)
Italian Senate
StartupDelta

Videos

François Garnier (Ipsen)
François Garnier 6 December 2019 Paris
François Garnier (Ipsen)
François Garnier 8 December 2017 Paris

Articles

358 Bulletin

Dimitri Giotakos, François Garnier, Laurent Petit, Peter De Luyck The EU Commission prohibits a merger between two US companies active in the markets for aero-engines, avionics and other aircraft components and systems (GE / Honeywell)

358

"General Electric/Honeywell — An insight into the Commission’s investigation and decision"* Owing to the benefits of engine commonality, incumbency of engine suppliers is better assessed in terms of the installed base of engines on aircraft that are still in production. Nevertheless, to the (...)

13599 Review

Send a message